Trending...
- Stockdale Capital Announces Four New Major Hires
- High-Growth Power Infrastructure Play Targets AI Boom: 1606 Corp. Executes Aggressive Texas Expansion Strategy: 1606 Corp. (Stock Symbol: CBDW) $CBDW
- As AI Accelerates Software Delivery, ThinkSys Introduces Zero Critical Bugs Guarantee
Simon Veterinary Surgical offers new Synovetin OA® to treat lameness in dogs
LOS ANGELES - Californer -- Los Angeles dogs suffering from pain, lameness, and reduced activity due to arthritis can now find convenient, long-lasting relief at Simon Veterinary Surgical thanks to a new treatment offered by Dr. Patricia Simon.
Synovetin OA® is a treatment placed right in the dog's joints that reduces the inflammation and pain of osteoarthritis for up to one full year.
"For dogs with chronic joint pain, Synovetin OA is a simple, long-lasting, and safe treatment," according to Dr. Simon. "It treats inflammation and pain right where it happens – it doesn't go throughout the dog like pills, where you could have side effects."
Nearly 25% of US dogs suffer from osteoarthritis, causing pain, lameness, limping, limited movement and a poor quality of life. Many current treatments require daily administrations to provide short-term relief. However, clinical trial data has shown that just one treatment with Synovetin OA relieves pain and inflammation and improves mobility for up to one year.
More on The Californer
"We're excited to be one of the very first veterinary hospitals offering Synovetin OA," Dr. Simon said. "Though my specialty is orthopedic surgery, it is no longer the only option for my patients."
This procedure involves the use of radiotherapy and Dr. Simon's team has completed the necessary training and licensing required to use Synovetin OA in all joints - other licensed clinics are usually only approved for elbows.
The active agent of Synovetin OA, developed by Exubrion Therapeutics®, is tin-117m, a unique medical radiotherapeutic. Synovetin OA:
More on The Californer
Simon Veterinary Surgical is a woman-owned small business serving the Greater Los Angeles area. Dr. Patricia Simon is a rare veterinary surgeon with comprehensive knowledge, experience, and proficiency in a wide range of orthopedic and advanced soft tissue procedures. Alongside her expert team, Dr. Simon has become one of the most sought after surgeons in the area. Their pet hospital facilities are fully equipped, allowing them to offer exceptional veterinary care, surgery, diagnostic imaging, and lab work in one location.
For more information about the procedure, contact Simon Veterinary Surgical at (310) 402-3573 or info@simonvetsurgical.com, or visit us at simonvetsurgical.com.
Information about Synovetin OA can be found at activedognow.com.
Synovetin OA® is a treatment placed right in the dog's joints that reduces the inflammation and pain of osteoarthritis for up to one full year.
"For dogs with chronic joint pain, Synovetin OA is a simple, long-lasting, and safe treatment," according to Dr. Simon. "It treats inflammation and pain right where it happens – it doesn't go throughout the dog like pills, where you could have side effects."
Nearly 25% of US dogs suffer from osteoarthritis, causing pain, lameness, limping, limited movement and a poor quality of life. Many current treatments require daily administrations to provide short-term relief. However, clinical trial data has shown that just one treatment with Synovetin OA relieves pain and inflammation and improves mobility for up to one year.
More on The Californer
- Colette Barris's Open Letter To Revolt's Detavio Samuels 'The BlackPrint' Interview Of Kenya Barris
- NYC Composer/Educator Launches Debut Children's Book to Fantastic Reviews
- EFA Announces 2026 Editorial Rate Chart
- Red5 Taps PubNub to Power the Next Era of Real-Time Interactive Streaming
- Connect Convenes Regional Leaders to Amplify San Diego's Innovation Momentum
"We're excited to be one of the very first veterinary hospitals offering Synovetin OA," Dr. Simon said. "Though my specialty is orthopedic surgery, it is no longer the only option for my patients."
This procedure involves the use of radiotherapy and Dr. Simon's team has completed the necessary training and licensing required to use Synovetin OA in all joints - other licensed clinics are usually only approved for elbows.
The active agent of Synovetin OA, developed by Exubrion Therapeutics®, is tin-117m, a unique medical radiotherapeutic. Synovetin OA:
- Reduces inflammation and relieves chronic canine OA pain
- Eliminates the key drivers of inflammation and pain
- Is administered just once a year and can be re-administered again after a year, if needed
- Is safe; no significant side effects were seen during clinical trials
- Is given in the hospital and the dog can normally return home the same day
- Can be used along with other treatments for OA pain management, if needed
More on The Californer
- Shoutout Joseph Neibich aka Nybyk
- Meet Joseph Neibich aka Joseph Nybyk of Beachwood Canyon
- Div Zero: A Spatial Mystery Built for the Evolving Future of Apple Vision Pro
- SoCal Locksmith With 113K YouTube Subscribers Shares Car Theft Prevention Tips
- LARUS Launches Business Continuity Framework for IPv4-Dependent Networks
Simon Veterinary Surgical is a woman-owned small business serving the Greater Los Angeles area. Dr. Patricia Simon is a rare veterinary surgeon with comprehensive knowledge, experience, and proficiency in a wide range of orthopedic and advanced soft tissue procedures. Alongside her expert team, Dr. Simon has become one of the most sought after surgeons in the area. Their pet hospital facilities are fully equipped, allowing them to offer exceptional veterinary care, surgery, diagnostic imaging, and lab work in one location.
For more information about the procedure, contact Simon Veterinary Surgical at (310) 402-3573 or info@simonvetsurgical.com, or visit us at simonvetsurgical.com.
Information about Synovetin OA can be found at activedognow.com.
Source: Simon Veterinary Surgical
Filed Under: Medical
0 Comments
Latest on The Californer
- AI Disruption Meets Marine Scale: Off The Hook YS, Inc. (N Y S E American: OTH) Targets Breakout Growth with NextBoat Launch and Aggressive Expansion
- Targeting the Billion-Dollar U.S. Countermeasure Market With AI-Driven Biodefense Platform: Lunai Bioworks (N A S D A Q: LNAI)
- A-One Janitorial Wins $152M AI Campus Contract — Meta, Microsoft, Google, and AWS
- New Global Standard for Transparency Across Critical Resources and Energy Markets: SMX (Security Matters) PLC (N A S D A Q: SMX)
- Forced Psychiatric Hospitalization Fails Vulnerable People: CCHR Urges Repeal Amid Rising U.S. Policies
- Surging Into High-Performance AI With $AMD Partnership, Patent Expansion, and Strengthened Balance Sheet: Avalon GloboCare Corp. (N A S D A Q: ALBT)
- Kiko Nation Launches Mobile App to Modernize Livestock Management and Digital Animal Registry
- NEW MANAGEMENT BOOK: Creating a Joy-Centric Culture
- Countrywide Rental Strengthens Waste Management Services Across Bankston Campuses
- Burbank Startup XBYZ LLC Launches Full-Service Business Platform for California Entrepreneurs
- Official Statement On The Passing Of KiKi Shepard From The Shepard Family
- QuickTrack by Datalex Transforms Retail Promoter Management with Claude AI and Real-Time Insights
- Kaltra Introduces Seasonal Discounts on Replacement Coils for Carrier, York, and Trane Chillers
- Fashion Sourcing — Simplifying Global Sourcing with Transparency in Manufacturing
- Fashion Sourcing — The B2B Online Marketplace for Custom Clothing Manufacturing
- Evolve Construction Mobilizes Commercial Storm Response Across Illinois With AI-Powered Damage Documentation and Public Adjusters Partnership
- On The Mark Digital Launches AISEO Services for Local Business AI Visibility
- High5VR Announces World's First Fully Immersive First-Person VR Movie
- HomeIQ Academy Launches Free Buyer Education Platform to Help Real Estate Agents Close More Deals
- The World's First Fully Regenerative Economy: Securing Energy, Food, and a Clean Planet
